Table 1. Sample Characteristics (N=311).
| Total (N = 311) | Non-adherent (N = 174) | Partially adherent (N = 90) | Adherent (N = 47) | p-value | |
|---|---|---|---|---|---|
| Age, years | 60 (±11.9) | 59 (±12.5) | 61 (±10.2) | 63 (±11.9) | 0.056 |
|
| |||||
| Gender | 0.503 | ||||
| Male | 201 (64.6%) | 117 (67.2%) | 54 (60.0%) | 30 (63.8%) | |
| Female | 110 (35.4%) | 57 (32.8%) | 36 (40.0%) | 17 (36.2%) | |
|
| |||||
| Marital Status | 0.052 | ||||
| Single/divorced/widow | 126 (40.5%) | 63 (36.2%) | 46 (51.1%) | 17 (36.2%) | |
| Married/co-habitating | 185 (59.5%) | 111 (63.8%) | 44 (48.9%) | 30 (63.8%) | |
|
| |||||
| Ethnicity | 0.006 | ||||
| White | 206 (66.2%) | 105 (60.3%) | 61 (67.8%) | 40 (85.1%) | |
| Minority | 105 (33.8%) | 69 (39.7%) | 29 (32.2%) | 7 (14.9%) | |
|
| |||||
| NYHA class | 0.777 | ||||
| I/II | 112 (36.0%) | 62 (35.6%) | 31 (34.4%) | 19 (40.4%) | |
| III/IV | 199 (64.0%) | 112 (64.4%) | 59 (65.6%) | 28 (59.6%) | |
|
| |||||
| Ischemic etiology of HF | 220 (70.7%) | 113 (64.9%) | 68 (75.6%) | 39 (83.0%) | 0.027 |
|
| |||||
| LVEF | 0.155 | ||||
| ≤ 40% | 200 (64.3%) | 107 (61.5%) | 57 (63.3%) | 36 (76.6%) | |
| > 40% | 111 (35.7%) | 67 (38.5%) | 33 (36.7%) | 11 (23.4%) | |
|
| |||||
| Charlson Comorbidity Index | 3.3 (±1.9) | 3.2 (±1.8) | 3.6 (±2.0) | 3.5 (±2.1) | 0.152 |
|
| |||||
| Self-care Management† | 55.5 (±20.5) | 49.4 (±19.4) | 59.9 (±19.3) | 70.0 (±17.6) | <.001 |
|
| |||||
| Medications | |||||
| ACEI or ARB (n=310) | 254 (81.9%) | 148 (85.1%) | 71 (79.8%) | 35 (74.5%) | 0.202 |
| Beta Blocker (n=309) | 267 (86.4%) | 149 (85.6%) | 75 (85.2%) | 43 (91.5%) | 0.542 |
| Diuretics | 245 (78.8%) | 124 (71.3%) | 75 (83.3%) | 46 (97.9%) | <.001 |
Note. Values are mean (±SD) or n (%).
NYHA=New York Heart Association; HF= Heart Failure; ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker
†
Significant group difference among all three groups